Education
About Us
Working with TipRanks
Follow Us
Nova Eye Medical Ltd (AU:EYE)
:EYE
Total Valuation
Nova Eye Medical has a market cap or net worth of AU$39.88M. The enterprise value is AU$28.79M.
Market CapAU$39.88M
Enterprise ValueAU$28.79M
Share Statistics
Nova Eye Medical has 284,833,280 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding284,833,280
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nova Eye Medical’s return on equity (ROE) is -0.48 and return on invested capital (ROIC) is -51.16%.
Return on Equity (ROE)-0.48
Return on Assets (ROA)-0.34
Return on Invested Capital (ROIC)-51.16%
Return on Capital Employed (ROCE)-0.53
Revenue Per Employee97.23K
Profits Per Employee0.00
Employee Count301
Asset Turnover1.10
Inventory Turnover3.27
Valuation Ratios
The current PE Ratio of Nova Eye Medical is ―. Nova Eye Medical’s PEG ratio is 0.20.
PE Ratio―
PS Ratio0.93
PB Ratio1.43
Price to Fair Value1.43
Price to FCF-4.14
Price to Operating Cash Flow-5.82
PEG Ratio0.20
Income Statement
In the last 12 months, Nova Eye Medical had revenue of 29.27M and earned -9.06M in profits. Earnings per share was -0.04.
Revenue29.27M
Gross Profit20.07M
Operating Income-11.25M
Pretax Income-9.06M
Net Income-9.06M
EBITDA-8.98M
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -6.15M and capital expenditures -298.00K, giving a free cash flow of -6.45M billion.
Operating Cash Flow-6.15M
Free Cash Flow-6.45M
Free Cash Flow per Share-0.02
Dividends & Yields
Nova Eye Medical pays an annual dividend of AU$0.414, resulting in a dividend yield of ―
Dividend Per ShareAU$0.414
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.21
52-Week Price Change0.00%
50-Day Moving Average0.14
200-Day Moving Average0.13
Relative Strength Index (RSI)53.37
Average Volume (3m)297.00K
Important Dates
Nova Eye Medical upcoming earnings date is Feb 19, 2026, TBA (Confirmed).
Last Earnings DateAug 27, 2025
Next Earnings DateFeb 19, 2026
Ex-Dividend DateJul 21, 2020
Financial Position
Nova Eye Medical as a current ratio of 2.39, with Debt / Equity ratio of 15.91%
Current Ratio2.39
Quick Ratio1.85
Debt to Market Cap0.00
Net Debt to EBITDA0.23
Interest Coverage Ratio-71.18
Taxes
In the past 12 months, Nova Eye Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nova Eye Medical EV to EBITDA ratio is -2.80, with an EV/FCF ratio of -3.83.
EV to Sales0.86
EV to EBITDA-2.80
EV to Free Cash Flow-3.83
EV to Operating Cash Flow-4.09
Balance Sheet
Nova Eye Medical has AU$5.05M in cash and marketable securities with AU$3.02M in debt, giving a net cash position of AU$2.04M billion.
Cash & Marketable SecuritiesAU$5.05M
Total DebtAU$3.02M
Net CashAU$2.04M
Net Cash Per Share<AU$0.01
Tangible Book Value Per ShareAU$0.05
Margins
Gross margin is 64.54%, with operating margin of -38.43%, and net profit margin of -30.95%.
Gross Margin64.54%
Operating Margin-38.43%
Pretax Margin-30.95%
Net Profit Margin-30.95%
EBITDA Margin-30.70%
EBIT Margin-38.43%
Analyst Forecast
The average price target for Nova Eye Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast25.47%
EPS Growth Forecast14.08%